Forest and Deloitte to collaborate

ConvergeHEALTH by Deloitte has entered into a multi-year collaboration with Forest Labs and Intermountain Healthcare to conduct outcomes research. The collaboration will leverage next-generation analytics, insights from real-world evidence and collaborative research to better understand patient outcomes and success factors. Its initial focus is respiratory disease.

Launched in February, ConvergeHEALTH is Deloitte's business unit combining analytics products with the organization's consulting capabilities.

Dr. Shailja Dixit, executive director, HEOR, at Forest, said, “this collaboration has the potential to provide unique insights into respiratory disease.” The parties said they will leverage EMR data to help understand associated outcomes for treatments and filter for sub-populations using phenotypic characteristics and medical associations.

You must be a registered member of MMM to post a comment.
close

Next Article in Features


Email Newsletters


Specialty medicines continue to be a hot category, one in which spending has surged behind products that treat medicine's most complex diseases. This eBook lays out the needs and hurdles along the specialty drug pathway, explaining how stakeholders are working to get meds into patients' hands and ease their experience. Click here to download.